Ruthenium(II) mixed-ligand complex containing 2-(4'-benzyloxy-phenyl)imidazo[4,5-f][1,10]phenanthroline: synthesis, DNA-binding and photocleavage studies
- PMID: 17316812
- DOI: 10.1016/j.jinorgbio.2006.12.016
Ruthenium(II) mixed-ligand complex containing 2-(4'-benzyloxy-phenyl)imidazo[4,5-f][1,10]phenanthroline: synthesis, DNA-binding and photocleavage studies
Abstract
A novel polypyridyl ligand 2-(4'-benzyloxyphenyl)imidazo[4,5-f][1,10]phenanthroline (BPIP) and its complex [Ru(bpy)2(BPIP)]2+ (1) (bpy=2,2'-bipyridine) and (2) [Ru(phen)2(BPIP)]2+) (phen=1,10-phenanthroline) have been synthesized and characterized by elemental analysis, electrospray mass spectra and 1H NMR. The DNA-binding properties of the two complexes were investigated by spectroscopic and viscosity measurements. The results suggest that both complexes bind to DNA via an intercalative mode. Both complexes can enantioselectively interact with calf thymus DNA (CT-DNA) in a way. The Lambda enantiomer of complex 1 is slightly predominant for binding to CT-DNA to the Delta enantiomer. Under irradiation at 365 nm, both complexes have also been found to promote the photocleavage of plasmid pBR 322 DNA. Inhibitors studies suggest that singlet oxygen ((1)O2) and hydroxyl radical (*OH) play a significant role in the cleavage mechanism for both complexes. Moreover, the DNA-binding and photocleavage properties of both complexes were compared with that of [Ru(bpy)2(BPIP)]2+ and [Ru(phen)2(BPIP)]2+. The experimental results indicate that methene group existence or not have a significant effect on the DNA-binding and cleavage mechanism of these complexes.
Similar articles
-
Synthesis, characterization, DNA-binding and photocleavage studies of [Ru(bpy)2(PPIP)]2+ and [Ru(phen)2(PPIP)]2+.J Inorg Biochem. 2005 Feb;99(2):513-20. doi: 10.1016/j.jinorgbio.2004.10.028. J Inorg Biochem. 2005. PMID: 15621284
-
Synthesis, DNA-binding and photocleavage studies of ruthenium(II) complex with 2-(3'-phenoxyphenyl)imidazo[4,5-f][1,10]phenanthroline.J Inorg Biochem. 2007 Jan;101(1):56-63. doi: 10.1016/j.jinorgbio.2006.08.006. Epub 2006 Aug 30. J Inorg Biochem. 2007. PMID: 17011036
-
DNA interactions of a functionalized ruthenium(II) mixed-polypyridyl complex [Ru(bpy)2ppd]2+.J Inorg Biochem. 2006 Sep;100(9):1487-94. doi: 10.1016/j.jinorgbio.2006.04.008. J Inorg Biochem. 2006. PMID: 16766033
-
Correlation Between Molecular Modelling and Spectroscopic Techniques in Investigation With DNA Binding Interaction of Ruthenium(II) Complexes.J Fluoresc. 2017 Mar;27(2):587-594. doi: 10.1007/s10895-016-1986-x. Epub 2016 Dec 6. J Fluoresc. 2017. PMID: 27924438 Review.
-
DNA binding, photocleavage, and topoisomerase inhibition of functionalized ruthenium(II)-polypyridine complexes.Chem Biodivers. 2008 Oct;5(10):1962-1979. doi: 10.1002/cbdv.200890181. Chem Biodivers. 2008. PMID: 18972534 Review.
Cited by
-
Interaction with a Biomolecule Facilitates the Formation of the Function-Determining Long-Lived Triplet State in a Ruthenium Complex for Photodynamic Therapy.J Phys Chem A. 2022 Mar 3;126(8):1336-1344. doi: 10.1021/acs.jpca.1c09968. Epub 2022 Feb 18. J Phys Chem A. 2022. PMID: 35179905 Free PMC article. Clinical Trial.
-
Breaking the barrier: an osmium photosensitizer with unprecedented hypoxic phototoxicity for real world photodynamic therapy.Chem Sci. 2020 Aug 3;11(36):9784-9806. doi: 10.1039/d0sc03008b. eCollection 2020 Sep 28. Chem Sci. 2020. PMID: 33738085 Free PMC article.
-
Os(II) Oligothienyl Complexes as a Hypoxia-Active Photosensitizer Class for Photodynamic Therapy.Inorg Chem. 2020 Nov 16;59(22):16341-16360. doi: 10.1021/acs.inorgchem.0c02137. Epub 2020 Oct 30. Inorg Chem. 2020. PMID: 33126792 Free PMC article.
-
DNA studies of newly synthesized heteroleptic platinum(II) complexes [Pt(bpy)(iip)](2+) and [Pt(bpy)(miip)](2.).J Biol Inorg Chem. 2016 Apr;21(2):163-75. doi: 10.1007/s00775-015-1317-8. Epub 2015 Dec 1. J Biol Inorg Chem. 2016. PMID: 26626200
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources